Thyroid function in children with perinatal human immunodeficiency virus type 1 infection

Thyroid

Volumn 10, Issue 6, 2000, Pages 499-505

  Chiarelli, F ^a,c   Galli, L ^b   Verrotti, A ^a   Di Ricco, L ^a   Vierucci, A ^b   De Martino, M ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Ospedale Policlinico   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; DNA POLYMERASE; LAMIVUDINE; LIOTHYRONINE; PENTAMIDINE ISETHIONATE; RITONAVIR; SAQUINAVIR; STAVUDINE; SULFAMETHOXAZOLE; THYROGLOBULIN; THYROID PEROXIDASE; THYROTROPIN; TRIMETHOPRIM; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CHILD; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PERINATAL INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROGLOBULIN BLOOD LEVEL; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; VIRUS LOAD; WESTERN BLOTTING;

EID: 0033917723     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2000.10.499     Document Type: Article

References (30)

1. Bourdoux PP, DeWit SA, Servais GM, Clumeck N, Bonnyns MA 1991 Biochemical thyroid profile in patients infected with human immunodeficiency virus. Thyroid 1: 147-149.
2. Tang WW, Kaptein EM 1989 Thyroid hormone levels in the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. West J med 151:627-631.
3. Sato K, Ozawa M, Demura H 1989 Thyroid function in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 111:857-858.
4. Hirschfeld S, Laue L, Cutler GB Jr, Pizzo P 1996 Thyroid abnormalities in children infected with human immunodeficiency virus. J Pediatr 128:70-74.
5. Grunfeld C, Pang M, Doerrler W, Jensen P, Shimizu L, Feingold KR, Cavalieri RR 1993 Indices of thyroid function and weight loss in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Metabolism 10:1270-1276.
6. de Martino M, Tovo PA, Tozzi AE, Pezzotti P, Galli L, Liviadotti S, Caselli D, Massiloni E, Riga E, Fioredda F, Plebani A, Gabiano C, Zuccotti GV 1992 HIV-1 transmission through breast-milk: Apprasial of risk according to duration of feeding AIDS 6:991-997.
7. Galli L, de Martino M, Tovo PA, Gabiano C, Tulisso S, Vierucci A, Guerra M, Marchiso P, Plebani A, Zuccotti GV, Martino AM, Dalla Casa P, Stegagno M 1995 Onset of clinical signs in children with HIV-1 perinatal infection. AIDS 9:455-461.
8. Centers for Disease Control and Prevention 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 43:1-13.
9. Tovo PA, de Martino M, Gabiano C, Cappello N, D'Elia R, Loy A, Plebani A, Ferraris G, Zuccotti GV, Dalla Casa P, Ferraris G, Caselli D, Fundaro C, D'Argenio P, Galli L, Principi N, Stegagno M, Ruga E, Palomba E 1992 Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet 339:1249-1253.
10. de Martino M, Tovo PA, Galli L, Gabiano C, Veglia F, Giaquinto C, Tulisso S, Loy A, Ferraris G, Zuccotti GV, Clerici-Scholler M, Vierucci A 1994 Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet 343:191-195.
11. Querido A, Delange F, Dunn T, Fierro-Benitez R, Ibbertson HK, Koutras DA, Perinetti H 1974 Definitions of endemic goiter and cretinism, classification of goiter size and severity of endemias and survey techniques. In: Dunn JT, Meideros-Neto GA (eds) Endemic Goiter and Cretinism Continuing Threats to World Health. Pan American Health Organization Scientific Publication No 292, Washington, DC, p 267.
12. Tanner JM, Whitehouse RH 1976 Clinical longitudinal standards for height velocity, weight velocity and stages of puberty. Arch Dis Child 51:170-179.
13. de Martino M, Tovo PA, Galli L, Gabiano C, Cozzani S, Gotta G, Scarlatti G, Fiocchi A, Cocchi P, Marchiso P, Canino R, Mautone A, Chiappe F, Campelli A, Consolini R, Izzi G, Laverada A, Alberti S, Tozzi AE, Douse M 1991 Prognostic significance of immunologic changes in 675 infants perinatally exposed to human immunodeficiency virus. J Pediatr 119: 702-709.
14. Ramzaoui S, Jouen-Beades F, Gilbert D, Borsa-Lebas F, Michel Y, Hambert G, Tron F 1995 During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose Vb repertoire is similar to that of CD4+ CD38-T-cells. Clin Immunol Immunopath 77: 33-41.
15. Palumbo PE, Kwok S, Waters S, Wesley Y, Lewis D, Mc Kinney N, Bardaguez A, Connor EM, Oleske JM 1995 Viral measurement by polymerase chain reaction-based assays in human immunodeficiency virus-infected infants. J Pediatr 126:592-595.
16. Altman DG 1980 Statistical and ethics in medical research. III How large a sample? BMJ 281:1336-1338.
17. Schwartz LJ, Louis Y, Wu R, Wiznia A, Rubinstein A, Saenger P 1991 Endocrine function in children with human immu-nodeficiency virus infection. Am J Dis Child 145: 1248-1251.
18. Rapaport R 1996 Endocrine alterations in human immunodeficiency virus infections. In Lifshitz F (ed) Pediatric Endocrinology: A Clinical Guide. Marcel Dekker, New York, pp 809-819.
19. Chiarelli F, Tumini S, Verrotti A, Morgese G 1989 Effects of ketoacidosis and puberty on basal and TRH-stimulated thyroid hormones and TSH in children with diabetes mellitus. Horm Metabol Res 21:494-497.
20. Kaptein EM 1986 Thyroid hormone metabolism in illness. In: Henneman G (ed) Thyroid Hormone Metabolism. Marcel Dekker, New York, p. 297.
21. Hommes MJT, Romijn JA, Endert E, Adriaanse R, Brabant G, Eeftinck Schattenkerk JKM, Wiersinga WM, Sauerwein HP 1993 Hypothyroid-like regulation of the pituitary-thyroid axis in stable human immunodeficiency virus infection. Metabolism 42:556-561.
22. Feldt-Rasmussen U, Sestoft L, Berg H 1991 Thyroid function tests in patients with acquired immune deficiency syndrome and healthy HIV-1 positive outpatients. Eur J Clin Invest 21:59-63.
23. Ozawa M, Sato K, Han CD, Kawakami M, Tsushima T, Shizume K 1988 Effects of tumor necrosis factor alpha/cachectin on thyroid hormone metabolism in mice. Endocrinology 123:1461-1467.
24. Fujii T, Sato K, Ozawa M, Kasono K, Imamura M, Kanaji Y, Tsushima T, Shizume K 1989 Effects of interleukin 1 (IL-1) on thyroid hormone metabolism in mice: Stimulation by IL-1 of iodothyronine 5′-deiodinating activity (type I) in the liver. Endocrinology 124:167-174.
25. Dubuis JM, Dayer JM, Siegrist-Kaiser CA, Burger AG 1988 Human recombinant interleukin-1β decreases plasma thyroid hormone and thyroid stimulating hormone levels in rats. Endocrinology 123:2175-2181.
26. Belec L, Meillet D, Gresenguet G, Gherardi RK 1995 Increased tumor necrosis factor-alpha serum levels in patients with HIV wasting syndrome and euthyroid sick syndrome. J Acquir Immune Defic Syndr Hum Retrovirol 8: 212-214.
27. Lambert M, Zech F, De Nayer P, Jamez J, Vandercam B 1990 Elevation of serum thyroxine-binding globulin (but not of cortisol-binding globulin and sex hormone-binding globulin) associated with the progression of human immunodeficiency virus infection. Am J Med 89:748-751.
28. Mofeson LM, Korelitz J, Meyer III-WA, Bethel J, Rich K, Pahwa S, Moye J, Nugent R, Read J 1997 The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long term mortality risk in HIV-1 infected children. J Infect Dis 175:1029-1038.
29. Shearer WT, Qinn TC, Larussa P, Lew JP, Mofenson LM, Almy S, Rich K, Handelsman E, Diaz C, Pagano M, Smeriglio V, Kalish LA 1997 Viral load and disease progression in infants infected with human immunodeficiency virus type I. N Engl J Med 336:1337-1342.
30. Lo Presti JS, Fried JC, Spencer CA, Nicoloff JT 1989 Unique alterations of thyroid hormones indices in the acquired immunodeficiency syndrome. Ann Intern Med 110:970-975.